Yvan Jamilloux
0000-0001-5249-3650
Hospices civils de Lyon
57 papers found
Refreshing results…
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study
Therapeutic options in VEXAS syndrome: insights from a retrospective series
Evaluating the cost-consequence of a standardized strategy for the etiological diagnosis of uveitis (ULISSE study)
Orbital mass in ANCA-associated vasculitides: data on clinical, biological, radiological and histological presentation, therapeutic management, and outcome from 59 patients
BTNL2 gene polymorphism and sarcoid uveitis
18F-fluorodeoxyglucose positron emission tomography is useful for the diagnosis of intraocular sarcoidosis in patients with a normal CT scan
A Comparative Study of Characteristics and Outcomes of Patients with Proved and Suggested Sarcoid Uveitis Occurring after Ophthalmic Procedure
Mesenteric lymphadenitis as a presenting feature of Whipple’s disease: Value of PCR analysis
Uveitis of Unknown Etiology: Clinical and Outcome features. A Retrospective Analysis of 355 Patients
Successful treatment with anakinra of an HIV-associated immune reconstitution inflammatory syndrome mimicking adult-onset Still’s disease
Manifestations ophtalmologiques de la sarcoïdose : que doit savoir l’interniste ?
Re: Dick et al.: Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative ( Ophthalmology . 2018;125:757-773)
Contribution of diagnostic tests for the etiological assessment of uveitis, data from the ULISSE study (Uveitis: Clinical and medicoeconomic evaluation of a standardized strategy of the etiological diagnosis)
The pyrin inflammasome: from sensing RhoA GTPases-inhibiting toxins to triggering autoinflammatory syndromes
Impact des recommandations Afssaps 2009 sur la prise en charge de la maladie thromboembolique veineuse aux urgences : étude avant/après
Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasome
Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: A multicenter study of 132 patients
Reply
Les infections opportunistes au cours de la sarcoïdose
Péricardite récidivante : quoi de neuf en 2017 ?
Missing publications? Search for publications with a matching author name.